Boehringer sales tick upward 3% on big Pradaxa leap

Carly Helfand Boehringer Ingelheim's drugs Pradaxa and Trajenta are both facing obstacles, but sales of both are still growing–and revenues for the company are growing right ...

China sales rep says Novartis ordered her to bribe doctors

Tracy Staton Big Pharma, beware of your former (and possibly current) employees in China. Novartis is the latest drugmaker to be fingered for bribery by an anonymous whistleblower, ...

ChinaGate Now Engulfs Novartis As A Sales Rep Alleges Bribes

esilverman The latest drugmaker to become implicated in the bribery scandal overtaking the global pharmaceutical industry in China is Novartis. A former sales rep alleges the ...

Oncologists Continue To Shun Sales Reps More Than Other Docs

esilverman For the second consecutive year, oncologists posed the biggest obstacle to sales reps – 65 percent of oncologists placed moderate-to-severe restrictions on ...

Dendreon’s Provenge sales off again, expected to miss for the year

Eric Palmer Investors spanked the Seattle company severely in after-hours trading Thursday after it reported that sales of the drug were off 8% in the second quarter year-over-year ...

Lundbeck recruiting 200-plus sales reps for Brintellix launch

Tracy Staton Lundbeck is fired up and ready for its launch of the potential blockbuster antidepressant Brintellix. Though still awaiting regulatory approval, the Danish drugmaker is ...

Hypermarcas leaps ahead in Brazil with surprise profits, sales surge

Tracy Staton Brazilian drugmaker Hypermarcas shows that market savvy pays, even when an economy hits the skids. Despite an unexpected lag in GDP growth, Hypermarcas posted a surprise ...

Astellas to Establish Sales Affiliate in Singapore

mia.burns Tokyo – August 1, 2013 – Astellas Pharma Inc. (TSE: 4503) announced today that it has established its newest affiliate, Astellas Pharma Singapore Pte. Ltd. (“Astellas ...

Suffering from generic onslaught, Merck cuts sales forecast

Tracy Staton Merck cut its sales forecast and posted a 50% drop in quarterly earnings as it continues to absorb major hits to its once-blockbuster Singulair. The fact that profits beat ...

Biogen’s Tecfidera races past estimates with $192M in Q2 sales

Tracy Staton For its first quarter on the market, Biogen Idec's new multiple sclerosis pill Tecfidera racked up $ 192 million in sales. That's more than twice the $ 70-some ...

Faltering Eliquis leaves Bristol-Myers’ Q2 sales in the lurch

Tracy Staton As goes Eliquis, so goes Bristol-Myers Squibb. That's true this quarter anyway, with the company cutting its full-year revenue and earnings forecasts at the same time ...

GlaxoSmithKline sales tick up, but China probe will hit growth

Tracy Staton GlaxoSmithKline's second-quarter results took a back seat to the goings-on in China. But sales are up just a tick. Profits dropped, falling short of analyst expectations. ...
Page 5 of 9« First...34567...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS